Top Markets
#1 Nesa Nesa +796.23%
#2 Cortex Cortex +69.02%
#3 Merlin's Seal BTC Merlin's Seal BTC +45.98%
#4 Pons Pons +26.01%
#5 QuantixAI QuantixAI +23.56%
#6 EXOD EXOD +22.78%
#7 Instadapp Instadapp +16.92%
#8 OpenEden OpenEden +16.80%
#9 Movement Movement +13.85%
#10 Magma Finance Magma Finance +12.79%
Coin of the day
Nesa Nesa
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
YD Bio Limited Ordinary Shares YD Bio Limited Ordinary Shares

YD Bio Limited Ordinary Shares

YDES
Clasificación en acciones #19455
Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company... Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.
Precio por acción
$2.28
Última sincronización: 2026-07-31
Capitalización bursátil
$161.59M
Cambio (1 día)
3.70%
Cambio (1 año)
-82.92%
País
TW
Comercio YD Bio Limited Ordinary Shares (YDES)

Categoría

Healthcare
Ratio P/S de YD Bio Limited Ordinary Shares (YDES)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de YD Bio Limited Ordinary Shares, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de YD Bio Limited Ordinary Shares desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH